A molecular test, simple and reliable, is the modern scientific answer for colorectal cancer screening. Nikos Tsoulos: "Prevention is a personal responsibility" In an in-depth discussion [...]
Due to the rapid development of the local economy, an aging population, and lifestyle changes, colorectal cancer (CRC) has emerged as a serious public health issue in [...]
In the show "The Decathanians" on SKAI on Sunday 30/3, the new Colon AiQ test was discussed and the important role it will play in the prevention [...]
On the occasion of Colorectal Cancer Awareness Month, we participated in #DressInBlueDay, dressed in blue, sending the message: Colorectal cancer can be prevented, and early detection saves [...]
During March, we focus on 6 key reasons that prevent people from getting screened and break down these fears: 5+1 main reasons why people avoid colorectal [...]
IQ Genomix CEO Nikolaos Tsoulos, PhD, MBA, biochemist, talks to Harper's Bazaar about the innovative Colon AiQ test, a non-invasive test that detects colorectal cancer in early [...]
As part of the 44th Panhellenic Gastroenterology Conference, held at the Divani Caravel Hotel in Athens from November 28 to December 1, 2024, a Satellite Lecture was [...]
This year IQ Genomix participated in the 44th Panhellenic Congress of Gastroenterology, which was held at the Divani Caravel Hotel in Athens from November 28 to December [...]
With the aim of enhancing prevention in colorectal cancer, IQ Genomix introduces the new Colon AiQ molecular test. Based on innovative molecular biology methods, the test provides [...]
